Visible light induces matrix metalloproteinase-9 expression in rat eye

Journal of Neurochemistry

Volumn 103, Issue 6, 2007, Pages 2224-2233

  Papp, Andrea M ^a   Nyilas, Rita ^a   Szepesi, Zsuzsanna ^a   Lorincz, Magor L ^a   Takács, Eszter ^a   Ábrahám, István ^a   Szilágyi, Nóra ^a   Tóth, Júlia ^a   Medveczky, Péter ^a   Szilágyi, László ^a   Juhász, Gábor ^a,a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

B wave; Electroretinogram; Gelatinase B; GM6001; Light; Matrix metalloproteinase 9

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; ILOMASTAT; XYLAZINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B WAVE; CONTROLLED STUDY; LIGHT; LIGHT INTENSITY; LIGHT STRESS; MALE; NONHUMAN; PHOTOSTIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ADAPTATION, OCULAR; ANIMALS; DARK ADAPTATION; ENZYME INDUCTION; ENZYME INHIBITORS; LIGHT; MALE; MATRIX METALLOPROTEINASE 9; MEMBRANE POTENTIALS; NEURONAL PLASTICITY; PHOTIC STIMULATION; PHOTOTRANSDUCTION; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RNA, MESSENGER; STRESS; VISION;

ANIMALIA; RATTUS;

EID: 36448962761     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04917.x     Document Type: Article

References (54)

1. Abu El-Asrar A. M., Dralands L., Veckeneer M., Geboes K., Missotten L., Van Aelst I. Opdenakker G. (1998) Gelatinase B in proliferative vitreoretinal disorders. Am. J. Ophthalmol. 125, 844 851.
2. Fini M. E., Girard M. T. Matsubara M. (1992) Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol. Suppl. 202, 26 33.
3. Galambos R., Szabó-Salfay O., Barabás P., Pálhalmi J., Szilágyi N. Juhász G. (2000) Temporal distribution of ganglion cell voleys in the normal rat optic nerve. Proc. Natl Acad. Sci. USA 97, 13454 13459.
4. Glickman R. D. (2002) Phototoxicity to the retina: mechanisms of damage. Int. J. Toxicol. 21, 473 490.
5. Gordon W. C., Casey D. M., Lukiw W. J. Bazan N. G. (2002) DNA damage and repair in light-induced photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 43, 3511 3521.
6. Gu Z., Kaul M., Yan B., Kridel S. J., Cui J., Strongin A., Smith J. W., Liddington R. C. Lipton S. A. (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297, 1186 1190.
7. Gursoy-Ozdemir Y., Qiu J., Matsuoka N., Bolay H., Bermpohl D., Jin H., Wang X., Rosenberg G. A., Lo E. H. Moskowitz M. A. (2004) Cortical spreading depression activates and upregulates MMP-9. J. Clin. Invest. 113, 1447 1455.
8. Hafezi F., Marti A., Munz K. Remé C. E. (1997a) Light-induced apoptosis: differential timing in the retina and pigment epithelium. Exp. Eye Res. 64, 963 970.
9. Hafezi F., Steinbach J. P., Marti A., Munz K., Wang Z.-Q., Wagner E. F., Aguzzi A. Remé C. E. (1997b) The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat. Med. 3, 346 349.
10. Hattori S., Fujisaki H., Kiriyama T., Yokoyama T. Irie S. (2002) Real-time zymography and reverse zymography: a method for detection of matrix metalloproteinases and their inhibitors using FITC-labeled collagen and casein as substrates. Anal. Biochem. 301, 27 34.
11. Heo J. H., Lucero J., Abumiya T., Koziol J. A., Copeland B. R. Zoppo G. J. (1999) Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 624 633.
12. Jourquin J., Tremblay E., Décanis N., Charton G., Hanessian S., Chollet A.-M., Le Dieguardher T., Khrestchatisky M. Rivera S. (2003) Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur. J. Neurosci. 18, 1507 1517.
13. Kaczmarek L., Lapinska-Dzwonek J. Szymczak S. (2002) Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? EMBO J. 21, 6643 6648.
14. Larsen P. H., Wells J. E., Stallcup W. B., Opdenakker G. Yong V. W. (2003) Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J. Neurosci., 23, 11127 11135.
15. Lee S.-R., Tsuji K., Lee S.-R. Lo E. H. (2004) Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. Neurobiol. Dis. 24, 671 678.
16. Mali R. S., Cheng M. Chintala S. K. (2005) Intravitreous injection of membrane depolarization agent causes retinal degeneration via matrix metalloproteinase-9. Invest. Ophthalmol. Vis. Sci. 46, 2125 2132.
17. Malik S., Cohen D., Meyer E. Perlman I. (1986) Light damage in the developing retina of the albino rat: an electroretinographic study. Invest. Ophthalmol. Vis. Sci. 27, 164 167.
18. Manabe S., Gu Z. Lipton S. A. (2005) Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 46, 4747 4753.
19. McCallum J. E. (1983) Improvement in somatosensory evoked response amplitude and neurologic function following DMSO in a cat model of chronic spinal cord compression. Ann. NY Acad. Sci. 411, 357 360.
20. Meighan S. E., Meighan P. C., Choudhury P., Davis C. J., Olson M. L., Zornes P. A., Wright J. W. Harding J. W. (2006) Effects of extracellular matrix-degrading proteases matrix metalloproteinase 3 and 9 on spatial learning and synaptic plasticity. J. Neurochem. 96, 1227 1241.
21. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R. M., Silva A. J., Kaczmarek L. Huntley G. W. (2006) Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J. Neurosci. 26, 1923 1934.
22. + hypothesis. J. Neurophysiol. 51, 164 182.
23. Noell W. K., Walker V. S., Kang B. S. Berman S. (1966) Retinal damage by light in rats. Invest. Ophthalmol. 5, 450 473.
24. Okada Y., Gonoji Y., Naka K., Tomita K., Nakanishi I., Iwata K., Yamashita K. Hayakawa T. (1992) Matrix metalloproteinase 9 (92-kDa gelatinase/Type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267, 21712 21719.
25. Penn J. S., Naash M. I. Anderson R. E. (1987) Effect of light history on retinal antioxidant and light damage susceptibility in the rat. Exp. Eye Res. 44, 779 788.
26. Planas A. M., Sole S. Justicia C. (2001) Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol. Dis. 8, 834 846.
27. Planas A. M., Justicia C., Sole S., Friguls B., Cervera A., Adell A. Chamorro A. (2002) Certain forms of matrix metalloproteinase-9 accumulate in the extracellular space after microdialysis probe implantation and middle cerebral artery occlusion/reperfusion. J. Cereb. Blood Flow Metab. 22, 918 925.
28. Raghava S., Hammond M. Kompella U. B. (2004) Periocular routes for retinal drug delivery. Expert Opin. Drug Deliv. 1, 99 114.
29. Rivera S., Ogier C., Jourquin J., Timsit S., Szklarczyk A. W., Miller K., Gearing A. J. H., Kaczmarek L. Khrestchatisky M. (2002) Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur. J. Neurosci. 15, 19 32.
30. Rosenberg G. A., Navratil M., Barone F. Feuerstein G. (1996) Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J. Cereb. Blood Flow Metab. 16, 360 366.
31. Salzmann J., Limb G. A., Khaw P. T., Gregor Z. J., Webster L., Chignell A. H. Charteris D. G. (2000) Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br. J. Ophthalmol. 84, 1091 1096.
32. Sawada M. Sato M. (1975) The effect of dimethyl sulfoxide on the neuronal excitability and cholinergic transmission in Aplysia ganglion cells. Ann. NY Acad. Sci. 243, 337 357.
33. Sivak J. M. Fini M. E. (2002) MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog. Ret. Eye Res. 21, 1 14.
34. Stolc S. Vlckova E. (1982) Facilitatory effect of some drugs on transmission in the frog sympathetic ganglion. J. Auton. Nerv. Syst. 6, 335 345.
35. Stone J., Maslim J., Valter-Kocsi K. et al. (1999) Mechanisms of photoreceptor death and survival in mammalian retina. Prog. Ret. Eye Res. 18, 689 735.
36. Sugawara T., Sieving P. A. Bush R. A. (2000) Quantitative relationship of the photopic and scotopic ERG to photoreceptor cell loss in light damaged rats. Exp. Eye Res. 70, 693 705.
37. Szabó-Salfay O., Pálhalmi J., Szatmári E., Barabás P., Szilágyi N. Juhász G. (2001) The electroretinogram and visual evoked potential of freely moving rats. Brain Res. Bull. 56, 7 14.
38. Szklarczyk A., Lapinska J., Rylski M., McKay R. D. G. Kaczmarek L. (2002) Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 22, 920 930.
39. Taishi P., Sanchez C., Wang Y., Fang J., Harding J. W. Krueger J. M. (2001) Conditions that affect sleep alter the expression of molecules associated with synaptic plasticity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R839 R845.
40. Tang Y., Kesavan P., Nakada M. T. Yan L. (2004) Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol. Cancer Res. 2, 73 80.
41. Tita B., Leone M. G., Casini M. L. et al. (2001) Corneal toxicity of xylazine and clonidine, in combination with ketamine, in the rat. Ophthalmic Res. 33, 345 352.
42. Van den Steen P. E., Dubois B., Nelissen I., Rudd P. M., Dwek R. A. Opdenakker G. (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375 536.
43. Wang X., Jung J., Asahi M., Chwang W., Russo L., Moskowitz M. A., Dixon C. E., Fini M. E. Lo E. H. (2000) Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037 7042.
44. Weeks J. G., Halme J. Woessner J. F. Jr. (1976) Extraction of collagenase from the involuting rat uterus. Biochim. Biophys. Acta 445, 205 214.
45. 2-Adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J. Neurosci. 16, 5986 5992.
46. Wenzel A., Grimm C., Marti A., Kueng-Hitz N., Hafezi F., Niemeyer G. Remé C. E. (2000) c-Fos controls the 'private pathway' of light-induced apoptosis of retinal photoreceptors. J. Neurosci. 20, 81 88.
47. Woessner J. F. Jr. (1995) Quantification of matrix metalloproteinases in tissue samples. Meth. Enzymol. 248, 510 528.
48. Wong T. T. L., Sethi C., Daniels J. T., Limb G. A., Murphy G. Khaw P. T. (2002) Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv. Ophthalmol. 47, 239 256.
49. Wright J. W., Masino A. J., Reichert J. R., Turner G. D., Meighan S. E., Meighan P. C. Harding J. W. (2003) Ethanol-induced impairment of spatial memory and brain matrix metalloproteinases. Brain Res. 963, 252 261.
50. Young R. W. (1994) The family of sunlight-related eye diseases. Optometry Vis. Sci. 71, 125 144.
51. Zhang X. Chintala S. K. (2004) Influence of interleukin-1 beta induction and mitogen-activated protein kinase phosphorylation on optic nerve ligation-induced matrix metalloproteinase-9 activation in the retina. Exp. Eye Res. 78, 849 860.
52. Zhang J. W., Deb S. Gottshall P. E. (1998) Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur. J. Neurosci., 10, 3358 3368.
53. Zhang X., Sakamoto T., Hata Y., Kubota T., Hisatomi T., Murata T., Ishibashi T. Inomata H. (2002) Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Exp. Eye Res. 74, 577 584.
54. Zhang X., Cheng M. Chintala S. K. (2004) Kainic-acid mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest. Ophthalmol. Vis. Sci., 45, 2374 2383.